Abbott Laboratories

From Powerbase
Revision as of 14:32, 12 February 2008 by Lynn Hill (talk | contribs) (Background)
Jump to: navigation, search

Background

Abbott Laboratories was founded in 1888 by Chicago physician Dr. Wallace Abbott. Abbott's principal businesses are global pharmaceuticals, nutritional and medical products. It describes itself as 'a broad-based health care company that discovers, develops, manufactures and markets products and services that span the continuum of care – from prevention and diagnosis to treatment and cure'[1].

In 2008, Abbott is listed as a client of Business Insights[2]

People

Senior Management Team

In february 2008, Abbott Laboratories report the following as their Senior Management Team[3]...

  • Miles D White - Chairman of the Board and Chief Executive Officer
  • Thomas C Freyman - Executive Vice President, Finance and Chief Financial Officer
  • James L Tyree - Executive Vice President , Pharmaceutical Products Group
  • Thomas F Chen - Senior Vice President, Nutrition International Operations
  • John C Landgraf - Senior Vice President, Global Pharmaceutical Manufacturing and Supply
  • Mary T Szela - Senior Vice President, Pharmaceutical Operations

Board of Directors

In February 2008, Abbott Laboratories report the following as members of their Board of Directors[4]...

Affilliations

In 2008, Abbott Laboratories provide a 'sample' of their partnerships[5] [6] [7]...

References

  1. Abbott Laboratories Corporate Profile Accessed 5th February 2008
  2. Business Insights Patient Power: The shift towards more informed, more powerful consumers of drugs Accessed 5th February 2008
  3. Abbott Laboratories Seniour Management Team Accessed 5th February 2008
  4. Abbott Laboratories Board of Directors Accessed 5th February 2008
  5. Abbott Laboratories Our Partnerships - Pharmaceuticals Accessed 5th January 2008
  6. Abbott Laboratories Our Partnerships - Medical Products Accessed 5th February 2008
  7. Abbott Laboratories Our Partnerships - Nutritional Products Accessed 5th February 2008